APO RESEARCH · REPORT
Chloroquine Phosphate
Chloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It is also being studied to treat COVID-19 as of 2020.
Product & engineering
Understand the product.
Chloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It is also being studied to treat COVID-19 as of 2020.
Selected research
Market Outlook & Growth Opportunities
Global Chloroquine Phosphate Market Outlook and Growth Opportunities 2026
Market perspective
Chloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It is also being studied to treat COVID-19 as of 2020.
Middle East and Africa is the dominant market in the global Chloroquine Phosphate market in terms of value. Sanofi and Bayer are the two players with the largest sales share, occupying 9.24% and 8.36% of the market share in 2019, respectively. And It is worth of noticing that chloroquine phosphate used in COVID-2019 will occupy 24.58% of the market share in 2020.
This report provides an overview of the global Chloroquine Phosphate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Chloroquine Phosphate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Chloroquine Phosphate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chloroquine Phosphate market size, projected growth trends, production technologies, key applications, and end-use industries.
Chloroquine Phosphate Segment by Company
Sanofi
Bayer
Ipca Laboratories
Cipla
Teva Pharmaceuticals
Merck
AstraZeneca
Pharco Pharmaceuticals
Indofarma
Jayson Pharmaceuticals
AM-Europharma
Humax Pharmaceutical
Atlantic Pharmaceutical
Ace Pharmaceuticals BV
Chloroquine Phosphate Segment by Type
Chloroquine Phosphate Injectable
Chloroquine Phosphate Oral
Chloroquine Phosphate Segment by Application
Malaria
COVID-19
Others
Chloroquine Phosphate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Chloroquine Phosphate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Chloroquine Phosphate market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Chloroquine Phosphate significant trends, drivers, influence factors in global and regions.
6. To analyze Chloroquine Phosphate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chloroquine Phosphate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chloroquine Phosphate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chloroquine Phosphate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Chloroquine Phosphate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chloroquine Phosphate industry.
Chapter 3: Detailed analysis of Chloroquine Phosphate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Chloroquine Phosphate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Chloroquine Phosphate in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Chloroquine Phosphate Injectable
- Chloroquine Phosphate Oral
Applications
- Malaria
- COVID-19
- Others
Companies covered
- Sanofi
- Bayer
- Ipca Laboratories
- Cipla
- Teva Pharmaceuticals
- Merck
- AstraZeneca
- Pharco Pharmaceuticals
- Indofarma
- Jayson Pharmaceuticals
- AM-Europharma
- Humax Pharmaceutical
- Atlantic Pharmaceutical
- Ace Pharmaceuticals BV
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Chloroquine Phosphate Sales Value (2021-2032)
- 1.2.2 Global Chloroquine Phosphate Sales Volume (2021-2032)
- 1.2.3 Global Chloroquine Phosphate Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Chloroquine Phosphate Market Dynamics
- 2.1 Chloroquine Phosphate Industry Trends
- 2.2 Chloroquine Phosphate Industry Drivers
- 2.3 Chloroquine Phosphate Industry Opportunities and Challenges
- 2.4 Chloroquine Phosphate Industry Restraints
3 Chloroquine Phosphate Market by Company
- 3.1 Global Chloroquine Phosphate Company Revenue Ranking in 2025
- 3.2 Global Chloroquine Phosphate Revenue by Company (2021-2026)
- 3.3 Global Chloroquine Phosphate Sales Volume by Company (2021-2026)
- 3.4 Global Chloroquine Phosphate Average Price by Company (2021-2026)
- 3.5 Global Chloroquine Phosphate Company Ranking (2024-2026)
- 3.6 Global Chloroquine Phosphate Company Manufacturing Base and Headquarters
- 3.7 Global Chloroquine Phosphate Company Product Type and Application
- 3.8 Global Chloroquine Phosphate Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Chloroquine Phosphate Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Chloroquine Phosphate Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Chloroquine Phosphate Market by Type
- 4.1 Chloroquine Phosphate Type Introduction
- 4.1.1 Chloroquine Phosphate Injectable
- 4.1.2 Chloroquine Phosphate Oral
- 4.2 Global Chloroquine Phosphate Sales Volume by Type
- 4.2.1 Global Chloroquine Phosphate Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Chloroquine Phosphate Sales Volume by Type (2021-2032)
- 4.2.3 Global Chloroquine Phosphate Sales Volume Share by Type (2021-2032)
- 4.3 Global Chloroquine Phosphate Sales Value by Type
- 4.3.1 Global Chloroquine Phosphate Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Chloroquine Phosphate Sales Value by Type (2021-2032)
- 4.3.3 Global Chloroquine Phosphate Sales Value Share by Type (2021-2032)
5 Chloroquine Phosphate Market by Application
- 5.1 Chloroquine Phosphate Application Introduction
- 5.1.1 Malaria
- 5.1.2 COVID-19
- 5.1.3 Others
- 5.2 Global Chloroquine Phosphate Sales Volume by Application
- 5.2.1 Global Chloroquine Phosphate Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Chloroquine Phosphate Sales Volume by Application (2021-2032)
- 5.2.3 Global Chloroquine Phosphate Sales Volume Share by Application (2021-2032)
- 5.3 Global Chloroquine Phosphate Sales Value by Application
- 5.3.1 Global Chloroquine Phosphate Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Chloroquine Phosphate Sales Value by Application (2021-2032)
- 5.3.3 Global Chloroquine Phosphate Sales Value Share by Application (2021-2032)
6 Chloroquine Phosphate Regional Sales and Value Analysis
- 6.1 Global Chloroquine Phosphate Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Chloroquine Phosphate Sales by Region (2021-2032)
- 6.2.1 Global Chloroquine Phosphate Sales by Region: 2021-2026
- 6.2.2 Global Chloroquine Phosphate Sales by Region (2027-2032)
- 6.3 Global Chloroquine Phosphate Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Chloroquine Phosphate Sales Value by Region (2021-2032)
- 6.4.1 Global Chloroquine Phosphate Sales Value by Region: 2021-2026
- 6.4.2 Global Chloroquine Phosphate Sales Value by Region (2027-2032)
- 6.5 Global Chloroquine Phosphate Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Chloroquine Phosphate Sales Value (2021-2032)
- 6.6.2 North America Chloroquine Phosphate Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Chloroquine Phosphate Sales Value (2021-2032)
- 6.7.2 Europe Chloroquine Phosphate Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Chloroquine Phosphate Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Chloroquine Phosphate Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Chloroquine Phosphate Sales Value (2021-2032)
- 6.9.2 South America Chloroquine Phosphate Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Chloroquine Phosphate Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Chloroquine Phosphate Sales Value Share by Country, 2025 VS 2032
7 Chloroquine Phosphate Country-level Sales and Value Analysis
- 7.1 Global Chloroquine Phosphate Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Chloroquine Phosphate Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Chloroquine Phosphate Sales by Country (2021-2032)
- 7.3.1 Global Chloroquine Phosphate Sales by Country (2021-2026)
- 7.3.2 Global Chloroquine Phosphate Sales by Country (2027-2032)
- 7.4 Global Chloroquine Phosphate Sales Value by Country (2021-2032)
- 7.4.1 Global Chloroquine Phosphate Sales Value by Country (2021-2026)
- 7.4.2 Global Chloroquine Phosphate Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.9.2 France Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.16.2 China Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.19.2 India Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Chloroquine Phosphate Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Chloroquine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Chloroquine Phosphate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Sanofi Chloroquine Phosphate Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Bayer
- 8.2.1 Bayer Company Information
- 8.2.2 Bayer Business Overview
- 8.2.3 Bayer Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Bayer Chloroquine Phosphate Product Portfolio
- 8.2.5 Bayer Recent Developments
- 8.3 Ipca Laboratories
- 8.3.1 Ipca Laboratories Company Information
- 8.3.2 Ipca Laboratories Business Overview
- 8.3.3 Ipca Laboratories Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Ipca Laboratories Chloroquine Phosphate Product Portfolio
- 8.3.5 Ipca Laboratories Recent Developments
- 8.4 Cipla
- 8.4.1 Cipla Company Information
- 8.4.2 Cipla Business Overview
- 8.4.3 Cipla Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Cipla Chloroquine Phosphate Product Portfolio
- 8.4.5 Cipla Recent Developments
- 8.5 Teva Pharmaceuticals
- 8.5.1 Teva Pharmaceuticals Company Information
- 8.5.2 Teva Pharmaceuticals Business Overview
- 8.5.3 Teva Pharmaceuticals Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Teva Pharmaceuticals Chloroquine Phosphate Product Portfolio
- 8.5.5 Teva Pharmaceuticals Recent Developments
- 8.6 Merck
- 8.6.1 Merck Company Information
- 8.6.2 Merck Business Overview
- 8.6.3 Merck Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Merck Chloroquine Phosphate Product Portfolio
- 8.6.5 Merck Recent Developments
- 8.7 AstraZeneca
- 8.7.1 AstraZeneca Company Information
- 8.7.2 AstraZeneca Business Overview
- 8.7.3 AstraZeneca Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.7.4 AstraZeneca Chloroquine Phosphate Product Portfolio
- 8.7.5 AstraZeneca Recent Developments
- 8.8 Pharco Pharmaceuticals
- 8.8.1 Pharco Pharmaceuticals Company Information
- 8.8.2 Pharco Pharmaceuticals Business Overview
- 8.8.3 Pharco Pharmaceuticals Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Pharco Pharmaceuticals Chloroquine Phosphate Product Portfolio
- 8.8.5 Pharco Pharmaceuticals Recent Developments
- 8.9 Indofarma
- 8.9.1 Indofarma Company Information
- 8.9.2 Indofarma Business Overview
- 8.9.3 Indofarma Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Indofarma Chloroquine Phosphate Product Portfolio
- 8.9.5 Indofarma Recent Developments
- 8.10 Jayson Pharmaceuticals
- 8.10.1 Jayson Pharmaceuticals Company Information
- 8.10.2 Jayson Pharmaceuticals Business Overview
- 8.10.3 Jayson Pharmaceuticals Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Jayson Pharmaceuticals Chloroquine Phosphate Product Portfolio
- 8.10.5 Jayson Pharmaceuticals Recent Developments
- 8.11 AM-Europharma
- 8.11.1 AM-Europharma Company Information
- 8.11.2 AM-Europharma Business Overview
- 8.11.3 AM-Europharma Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.11.4 AM-Europharma Chloroquine Phosphate Product Portfolio
- 8.11.5 AM-Europharma Recent Developments
- 8.12 Humax Pharmaceutical
- 8.12.1 Humax Pharmaceutical Company Information
- 8.12.2 Humax Pharmaceutical Business Overview
- 8.12.3 Humax Pharmaceutical Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Humax Pharmaceutical Chloroquine Phosphate Product Portfolio
- 8.12.5 Humax Pharmaceutical Recent Developments
- 8.13 Atlantic Pharmaceutical
- 8.13.1 Atlantic Pharmaceutical Company Information
- 8.13.2 Atlantic Pharmaceutical Business Overview
- 8.13.3 Atlantic Pharmaceutical Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Atlantic Pharmaceutical Chloroquine Phosphate Product Portfolio
- 8.13.5 Atlantic Pharmaceutical Recent Developments
- 8.14 Ace Pharmaceuticals BV
- 8.14.1 Ace Pharmaceuticals BV Company Information
- 8.14.2 Ace Pharmaceuticals BV Business Overview
- 8.14.3 Ace Pharmaceuticals BV Chloroquine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Ace Pharmaceuticals BV Chloroquine Phosphate Product Portfolio
- 8.14.5 Ace Pharmaceuticals BV Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Chloroquine Phosphate Value Chain Analysis
- 9.1.1 Chloroquine Phosphate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Chloroquine Phosphate Sales Mode & Process
- 9.2 Chloroquine Phosphate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Chloroquine Phosphate Distributors
- 9.2.3 Chloroquine Phosphate Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst